Failure to thrive, and Respiratory distress

Diseases related with Failure to thrive and Respiratory distress

In the following list you will find some of the most common rare diseases related to Failure to thrive and Respiratory distress that can help you solving undiagnosed cases.

Top matches:

Interstitial lung disease due to ABCA3 deficiency is a rare genetic respiratory disease characterized by a variable clinical outcome ranging from a fatal respiratory distress syndrome in the neonatal period to chronic interstitial lung disease developing in infancy or childhood with chronic cough, rapid breathing, shortness of breath and recurrent pulmonary infections. Clinical manifestations of respiratory failure include grunting, intercostal retractions, nasal flaring, cyanosis, and progressive dyspnea.

INTERSTITIAL LUNG DISEASE DUE TO ABCA3 DEFICIENCY Is also known as pulmonary alveolar proteinosis, congenital, 3|interstitial lung disease due to abca3 deficiency|interstitial lung disease due to atp-binding cassette subfamily a member 3 deficiency

Related symptoms:

  • Failure to thrive
  • Hypertension
  • Respiratory distress
  • Patent ductus arteriosus
  • Respiratory failure


SOURCES: OMIM ORPHANET MENDELIAN

More info about INTERSTITIAL LUNG DISEASE DUE TO ABCA3 DEFICIENCY

Pulmonary alveolar proteinosis (PAP) is a rare lung disorder in which surfactant-derived lipoproteins accumulate excessively within pulmonary alveoli, causing severe respiratory distress. Three forms of PAP have been described: hereditary (usually congenital), secondary, and acquired. Hereditary PAP is associated with mutations in the CSF2RA gene or in genes encoding surfactant proteins. Secondary PAP develops in conditions in which there are reduced numbers or functional impairment of alveolar macrophages and is associated with inhalation of inorganic dust (silica) or toxic fumes, hematologic malignancies, pharmacologic immunosuppression, infections, and impaired CSF2RB (OMIM ) expression. Acquired PAP (OMIM ), the most common form, usually occurs in adults and is caused by neutralizing autoantibodies to CSF2 (OMIM ) (Martinez-Moczygemba et al., 2008).For a general phenotypic description and a discussion of genetic heterogeneity of congenital pulmonary surfactant metabolism dysfunction, see SMDP1 (OMIM ).

SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 Is also known as pulmonary alveolar proteinosis, congenital, 4|csf2ra deficiency|pap due to csf2ra deficiency

Related symptoms:

  • Growth delay
  • Failure to thrive
  • Respiratory insufficiency
  • Respiratory distress
  • Pneumonia


SOURCES: MESH OMIM MENDELIAN

More info about SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4

Related symptoms:

  • Generalized hypotonia
  • Growth delay
  • Failure to thrive
  • Feeding difficulties
  • Hepatomegaly


SOURCES: OMIM MENDELIAN

More info about COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19

Other less relevant matches:

Cardiomyopathy-hypotonia-lactic acidosis syndrome is characterised by hypertrophic cardiomyopathy, muscular hypotonia and the presence of lactic acidosis at birth. It has been described in two sisters (both of whom died within the first year of life) from a nonconsanguineous Turkish family. The syndrome is caused by a homozygous point mutation in the exon 3A of the SLC25A3 gene encoding a mitochondrial membrane transporter.

CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME Is also known as mpcd

Related symptoms:

  • Generalized hypotonia
  • Failure to thrive
  • Muscular hypotonia
  • Respiratory insufficiency
  • Respiratory distress


SOURCES: ORPHANET MESH OMIM MENDELIAN

More info about CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME

HIGM3, first described in humans by Ferrari et al. (2001), is characterized by hypogammaglobulinemia with normal or elevated levels of IgM.For a general phenotypic description and a discussion of genetic heterogeneity of immunodeficiency with hyper-IgM, see HIGM1 (OMIM ).

IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3; HIGM3 Is also known as hyper-igm syndrome 3

Related symptoms:

  • Failure to thrive
  • Hepatomegaly
  • Respiratory distress
  • Immunodeficiency
  • Pneumonia


SOURCES: OMIM MENDELIAN

More info about IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3; HIGM3

N-acetylglutamate synthase (NAGS) deficiency is a urea cycle disorder leading to hyperammonaemia.

HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY Is also known as hyperammonemia due to n-acetylglutamate synthetase deficiency|n-acetylglutamate synthetase deficiency|nags deficiency

Related symptoms:

  • Seizures
  • Global developmental delay
  • Failure to thrive
  • Cognitive impairment
  • Feeding difficulties


SOURCES: MESH ORPHANET OMIM MENDELIAN

More info about HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY

Surfactant protein C (SPC) deficiency is a rare autosomal dominant disease associated with progressive respiratory insufficiency and lung disease with a variable clinical course. The pathophysiology of the disorder is postulated to involve intracellular accumulation of a structurally defective SPC protein (Thomas et al., 2002).For a general phenotypic description and a discussion of genetic heterogeneity of pulmonary surfactant metabolism dysfunction, see SMDP1 (OMIM ).

SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2 Is also known as interstitial lung disease due to surfactant protein c deficiency|desquamative interstitial pneumonitis due to surfactant protein c deficiency|pulmonary alveolar proteinosis, congenital, 2

Related symptoms:

  • Failure to thrive
  • Pain
  • Respiratory insufficiency
  • Respiratory distress
  • Recurrent infections


SOURCES: OMIM MENDELIAN

More info about SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2

Inborn errors of pulmonary surfactant metabolism are genetically heterogeneous disorders resulting in severe respiratory insufficiency or failure in full-term neonates or infants. These disorders are associated with various pathologic entities, including pulmonary alveolar proteinosis (PAP), desquamative interstitial pneumonitis (DIP), or cellular nonspecific interstitial pneumonitis (NSIP) (Clark and Clark, 2005).A clinically similar disorder characterized by respiratory distress (OMIM ) can affect preterm infants, who show developmental deficiency of surfactant.Acquired PAP (OMIM ) is an autoimmune disorder characterized by the presence of autoantobodies to CSF2 (OMIM ). Genetic Heterogeneity of Pulmonary Surfactant Metabolism DysfunctionSee also SMDP2 (OMIM ), caused by mutation in the SPTPC gene (OMIM ) on 8p21; SMDP3 (OMIM ), caused by mutation in the ABCA3 gene (OMIM ) on 16p13; SMDP4 (OMIM ), caused by mutation in the CSF2RA gene (OMIM ) on Xp22; and SMDP5 (OMIM ), caused by mutation in the CSF2RB gene (OMIM ) on 22q12.

NEONATAL ACUTE RESPIRATORY DISTRESS DUE TO SP-B DEFICIENCY Is also known as neonatal acute respiratory distress due to surfactant protein b deficiency|pulmonary alveolar proteinosis, congenital, 1|interstitial lung disease due to surfactant protein b deficiency|interstitial lung disease, nonspecific, due to surfactant protein b d

Related symptoms:

  • Failure to thrive
  • Pain
  • Hypertension
  • Fever
  • Fatigue


SOURCES: OMIM ORPHANET MESH MENDELIAN

More info about NEONATAL ACUTE RESPIRATORY DISTRESS DUE TO SP-B DEFICIENCY

Immunodeficiency-19 (IMD19) is an autosomal recessive form of severe combined immunodeficiency (SCID) characterized by onset in early infancy of recurrent bacterial, viral, and fungal infections. Patients usually have chronic diarrhea, recurrent respiratory infections, and failure to thrive. Immunologic work-up shows a T cell-negative, B cell-positive, natural killer (NK) cell-positive phenotype. The disorder is lethal in early childhood without bone marrow transplantation (summary by Yu et al., 2011).

IMMUNODEFICIENCY 19; IMD19 Is also known as scid, t cell-negative, b cell-positive, nk cell-positive|cd3-delta deficiency|severe combined immunodeficiency, t cell-negative, b cell-positive, nk cell-positive

Related symptoms:

  • Failure to thrive
  • Fever
  • Respiratory distress
  • Diarrhea
  • Immunodeficiency


SOURCES: OMIM MENDELIAN

More info about IMMUNODEFICIENCY 19; IMD19

Interstitial lung and liver disease is an autosomal recessive disorder characterized by onset of respiratory insufficiency and progressive liver disease in infancy or early childhood. Pathologic examination of lung lavage is consistent with pulmonary alveolar proteinosis (summary by Hadchouel et al., 2015).

INTERSTITIAL LUNG AND LIVER DISEASE; ILLD Is also known as infantile liver failure syndrome 2, formerly|pulmonary alveolar proteinosis, reunion island|ilfs2, formerly

Related symptoms:

  • Generalized hypotonia
  • Failure to thrive
  • Anemia
  • Motor delay
  • Hepatomegaly


SOURCES: OMIM MENDELIAN

More info about INTERSTITIAL LUNG AND LIVER DISEASE; ILLD

Top 5 symptoms//phenotypes associated to Failure to thrive and Respiratory distress

Symptoms // Phenotype % cases
Tachypnea Common - Between 50% and 80% cases
Alveolar proteinosis Uncommon - Between 30% and 50% cases
Abnormal lung morphology Uncommon - Between 30% and 50% cases
Respiratory insufficiency Uncommon - Between 30% and 50% cases
Respiratory failure Uncommon - Between 30% and 50% cases

Other less frequent symptoms

Patients with Failure to thrive and Respiratory distress. may also develop some of the following symptoms:

Uncommon Symptoms - Between 30% and 50% cases

Acidosis Hepatomegaly Cyanosis Generalized hypotonia Interstitial pulmonary abnormality Desquamative interstitial pneumonitis Lactic acidosis Interstitial pneumonitis Hypoxemia Clubbing Cough Dyspnea

Rare Symptoms - Less than 30% cases

Vomiting Hypertension Fever Immunodeficiency Hepatic failure Chest pain Pain Hepatic steatosis Recurrent respiratory infections Elevated hepatic transaminase Growth delay Foam cells Tachycardia Pneumonia Feeding difficulties Apnea Neonatal respiratory distress Pulmonary fibrosis Decreased liver function Bronchitis Pulmonary infiltrates Autoimmunity Recurrent bronchitis Tubulointerstitial fibrosis Aminoaciduria Cholestasis Fatigue Abnormality of metabolism/homeostasis Weight loss Ventricular hypertrophy Pulmonary arterial hypertension Hepatitis Motor delay Anemia Severe combined immunodeficiency Combined immunodeficiency Abnormality of the liver Chronic diarrhea Recurrent otitis media Cirrhosis Hypothyroidism Respiratory tract infection Diarrhea Nonproductive cough Productive cough Right ventricular hypertrophy Hyperventilation Hemoptysis Lymphopenia Global developmental delay Recurrent infections Myopathy Abnormal mitochondrial shape Abnormality of the mitochondrion Severe muscular hypotonia Increased serum lactate Metabolic acidosis Hypertrophic cardiomyopathy Congestive heart failure Cardiomyopathy Neutropenia Muscular hypotonia Severe lactic acidosis Neonatal hypotonia Gastroesophageal reflux Crackles Restrictive ventilatory defect Chronic lung disease Patent ductus arteriosus Low-output congestive heart failure Decreased antibody level in blood Increased level of L-glutamic acid in blood Visual impairment Acute encephalopathy Hyperammonemia Coma Confusion Lethargy Aggressive behavior Hypoglycemia Encephalopathy Cognitive impairment Recurrent bacterial infections Seizures Impaired memory B cell generation IgE deficiency Absence of lymph node germinal center Impaired Ig class switch recombination Increased IgM level IgG deficiency IgA deficiency Severe failure to thrive


If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like Neuroblastoma and High myopia, related diseases and genetic alterations Optic atrophy and Downslanted palpebral fissures, related diseases and genetic alterations Hyperreflexia and Headache, related diseases and genetic alterations Ptosis and Lower limb muscle weakness, related diseases and genetic alterations